Kolakowska T, Molyneux S G
Am J Psychiatry. 1987 Feb;144(2):232-4. doi: 10.1176/ajp.144.2.232.
Platelet serotonin (5-HT) concentration did not significantly differ between control subjects (N = 45) and schizophrenic (N = 62) or chronic schizophrenic (N = 39) patients. No clinical feature was associated with hyperserotonemia, but the subgroup receiving benzodiazepines had a significantly higher 5-HT level than other patients.
血小板血清素(5-羟色胺,5-HT)浓度在对照组受试者(N = 45)与精神分裂症患者(N = 62)或慢性精神分裂症患者(N = 39)之间无显著差异。没有临床特征与高血清素血症相关,但接受苯二氮䓬类药物治疗的亚组患者的5-HT水平显著高于其他患者。